DEA Chopping Block: DATA-Waiver Requirement
On January 12, 2023, the Drug Enforcement Administration (DEA) confirmed in a letter to registrants that the Consolidated Appropriations Act of 2023 (P.L. 117-328) (the Act), which was signed into law on December 29, 2022, eliminated the “DATA-Waiver Program”. The removal of the DATA-Waiver (or X-waiver) will increase the pool of practitioners eligible to prescribe buprenorphine, a clinically-proven medication used to treat patients with opioid use disorder (OUD).
The Substance Abuse and Mental Health Services…